Showing results (121-130 of 308) with videos related to
Sort By:
Pageof 31
Cardiology|February 2, 2013
Unclassified pleomorphic and spindle cell pulmonary neoplasm with brain metastases after prasugrelVictor L Serebruany, James J Dinicolantonio, Mehmet Mustafa Can, et al.Swiss Medical Weekly|October 31, 2001
Platelet activation as a universal trigger in the pathogenesis of acute coronary events after cocaine abuseK P Callahan, A I Malinin, D Atar, et al.Journal of Human Hypertension|February 15, 2008
Effects of aliskiren, a renin inhibitor, on biomarkers of platelet activity, coagulation and fibrinolysis in subjects with multiple risk factors for vascular diseaseV L Serebruany, A Malinin, G Barsness, et al.Journal of Clinical Pharmacology|March 24, 2006
Antiplatelet activity during coadministration of the selective serotonin reuptake inhibitor paroxetine and aspirin in male smokers: a randomized, placebo-controlled, double-blind trialNicole Kotzailias, Toni Andonovski, Alexander Dukic, et al.Blood Coagulation & Fibrinolysis : an International Journal in Haemostasis and Thrombosis|July 6, 2016
CYP2C19 but not CYP2B6, CYP3A4, CYP3A5, ABCB1, PON1 or P2Y12 genetic polymorphism impacts antiplatelet response after clopidogrel in KoreansHong-Zhe Zhang, Moo Hyun Kim, Long-Zhe Guo, et al.Expert Review of Cardiovascular Therapy|October 30, 2015
Clopidogrel, prasugrel, ticagrelor or vorapaxar in patients with renal impairment: do we have a winner?Victor L Serebruany, Ales Tomek, Alex N Pokov, et al.American Journal of Hematology|December 26, 2003
Risk of bleeding complications with antiplatelet agents: meta-analysis of 338,191 patients enrolled in 50 randomized controlled trialsVictor L Serebruany, Alex I Malinin, Roswith M Eisert, et al.Reviews in Cardiovascular Medicine|December 27, 2021
Enoxaparin dose impacts blood cell phenotypes during mild SARS-CoV-2 infection: the observational single-center studyLiudmila Buryachkovskaya, Nikita Lomakin, Arthur Melkumyants, et al.Thrombosis Research|November 30, 1999
The flow cytometer model markedly affects measurement of ex vivo whole blood platelet-bound P-selectin expression in patients with chest pain: are we comparing apples with orangesV L Serebruany, D J Kereiakes, M R Dalesandro, et al.Cardiology|June 9, 2000
Clinical utility of available methods for determining platelet functionM E McKenzie, P A Gurbel, D J Levine, et al.Pageof 31